Maxim Group LLC is acting as the exclusive Financial Advisor for the transaction PHILADELPHIA, PA / ACCESS Newswire / ...

Only 6% of trials for FDA-approved drugs match America's diversity. Analysis reveals how trial location and design choices ...

Cleveland Clinic researchers are presenting final Phase 1 data from their novel study of a vaccine aimed at preventing triple ...

Newly published research in the Journal of Clinical Oncology reports on a phase 2 clinical trial that finds that children with a rare form of cancer called neuroblastoma which hasn’t responded to ...

Cleveland Clinic researchers are presenting final Phase I data from their novel study of a vaccine aimed at preventing triple ...

After decades of research, Phase 1 of a Cleveland Clinic study shows a breast cancer vaccine is safe and triggers an immune ...

The combination of talquetamab-tgvs and pomalidomide achieved an 85.7% objective response rate in relapsed/refractory multiple myeloma patients. Median progression-free survival was 25.8 months, with ...

Adding tucatinib (Tukysa) to first-line maintenance therapy with trastuzumab (Herceptin) and pertuzumab (Perjeta) delayed ...

An experimental oral drug claims to do the work of medications like GLP-1s without losing muscle mass.

Inflammation plays a critical role in the development and progression of neurovascular disorders and stroke, impacting both acute and chronic phases of ...

A Chinese biotech helmed by an AstraZeneca veteran has secured $108 million in series B funds, which the company will use to ...

In Williamson County, Southern Illinois Healthcare is expanding access to advanced cancer clinical trials, including a global ...